MIA-QSAR Modeling of the Anti-HIV-1 Protease Activities and Cytotoxicities of Ritonavir Analogs

Publisher： Bentham Science Publishers

E-ISSN： 2212-3911|7|4|269-281

ISSN： 1574-8863

Source： Current Drug Safety, Vol.7, Iss.4, 2012-09, pp. : 269-281

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

QSAR study on some arylsulfonamides as anti-HIV agents

By Ravichandran Veerasamy  

Medicinal Chemistry Research, Vol. 16, Iss. 7-9, 2007-12 ,pp. : 342-351

Springer Publishing Company

Access to resources Recommend Favorite

Ritonavir-boosted protease inhibitors in HIV therapy

By Hull Mark W.   Montaner Julio S. G.  

Annals of Medicine, Vol. 43, Iss. 5, 2011-08 ,pp. : 375-388

Informa Healthcare

Access to resources Recommend Favorite

Ten Years of the MIA-QSAR Strategy: Historical Development and Applications

By  

International Journal of Quantitative Structure-Property Relationships (IJQSPR)*, Vol. 1, Iss. 1, 2016-01 ,pp. : 64-77

IGI Global_journal

Access to resources Recommend Favorite

Effects of NO‐Hybridization on the Immunomodulatory Properties of the HIV Protease Inhibitors Lopinavir and Ritonavir

By  

BASIC AND CLINICAL PHARMACOLOGY & TOXICOLOGY (ELECTRONIC), Vol. 117, Iss. 5, 2015-11 ,pp. : 306-315

John Wiley & Sons Inc

Access to resources Recommend Favorite

Structural findings of quinolone carboxylic acids in cytotoxic, antiviral, and anti-HIV-1 integrase activity through validated comparative molecular modeling studies

By Adhikari Nilanjan   Halder Amit   Mondal Chanchal   Jha Tarun  

Medicinal Chemistry Research, Vol. 23, Iss. 6, 2014-06 ,pp. : 3096-3127

Springer Publishing Company

Access to resources Recommend Favorite